Galassi, A.; Ciceri, P.; Bono, V.; Magagnoli, L.; Sala, M.; Artioli, L.; Rovito, R.; Hadla, M.; Yellenki, V.; D’Arminio Monforte, A.;
et al. Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines 2022, 10, 3251.
https://doi.org/10.3390/biomedicines10123251
AMA Style
Galassi A, Ciceri P, Bono V, Magagnoli L, Sala M, Artioli L, Rovito R, Hadla M, Yellenki V, D’Arminio Monforte A,
et al. Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines. 2022; 10(12):3251.
https://doi.org/10.3390/biomedicines10123251
Chicago/Turabian Style
Galassi, Andrea, Paola Ciceri, Valeria Bono, Lorenza Magagnoli, Matteo Sala, Luisa Artioli, Roberta Rovito, Mohamad Hadla, Vaibhav Yellenki, Antonella D’Arminio Monforte,
and et al. 2022. "Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19" Biomedicines 10, no. 12: 3251.
https://doi.org/10.3390/biomedicines10123251
APA Style
Galassi, A., Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’Arminio Monforte, A., Tincati, C., Cozzolino, M., & Marchetti, G.
(2022). Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines, 10(12), 3251.
https://doi.org/10.3390/biomedicines10123251